Image of The COVID-19 Pandemic : R&D and Intellectual Property Management for Acces to Diagnostics, Medicines and Vaccines

Artikel

The COVID-19 Pandemic : R&D and Intellectual Property Management for Acces to Diagnostics, Medicines and Vaccines

The ongoing rapid spread of COVID-19 is challenging the capacity of governments and of the World Health Organization (WHO) to timely put in place a global coordinated response to the pandemic. Developing countries and Least Developed Countries (LDCs) in particular in Africa are especially vulnerable to the unfolding effects of the public health crisis. A priority area for global collaboration is to advance research and development (R&D) for vaccines and medicines that are made available, affordable and accesible worldwide.

Ketersediaan
08002346.048 VIV tPerpustakaan DJKI TangerangTersedia namun tidak untuk dipinjamkan - Tidak Bisa Dipinjam
Informasi Detail
Judul Seri
POLICY BRIEF
No. Panggil
346.048 VIV t
Penerbit
Geneva : South Centre.,
Deskripsi Fisik
8 hlm
Bahasa
English
ISBN/ISSN
-
Klasifikasi
346.048
Tipe Isi
text
Tipe Media
other
Tipe Pembawa
-
Edisi
No. 73 April 2020
Subjek
Medicines
Diagnostics
Vaccines
Intellectual Property Management
Info Detail Spesifik
Viviana Munoz Tellez is Coordinator of the health, Intellectual Property and Biodiversity (HIPB) Programme at the South Centre, Geneva. The author would like to thank Dr Carlos Correa, Dr German Velasquez and Nirmalya Syam for useful comments and discussion.
Pernyataan Tanggungjawab
Versi lain/terkait

Tidak tersedia versi lain

Lampiran Berkas
Tidak Ada Data
Komentar
Anda harus masuk sebelum memberikan komentar